InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,116.27
(
1.03%
)
US TECH 100
17,420.00
(
2.01%
)
Dow Jones
38,663.18
(
1.14%
)
Brent Oil
83.51
(
-0.15%
)
Bitcoin
61,645.36
(
4.27%
)
Post# of 8512
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Fred Kadiddlehopper

Send PM Follow Ignore
Followers 28
Posts 4319
Boards Moderated 1
Alias Born 09/22/2006

Fred Kadiddlehopper

Re: None

Thursday, 03/16/2023 8:06:55 AM

Thursday, March 16, 2023 8:06:55 AM

Post# of 8512
Yet another PR: The "unique" Janssen license does not extend the royalty step down in any event.

On March 15, 2023, Halozyme Therapeutics, Inc. (the “Company”) issued a press release providing an update on a decision by the Opposition Division of the European Patent Office regarding one of the Janssen Biotech (“Janssen”) co-formulation patents for DARZALEX® (daratumumab) subcutaneous (SC) formulation and reaffirming revenue guidance for 2023 and its total royalty revenue projections of approximately $1 billion by 2027, and thereafter to at least 2030. The Company confirms that the license with Janssen is unique in that co-formulation patents covering DARZALEX SC with Halozyme’s ENHANZE® drug delivery technology do not extend the time for royalty step-down beyond 2024 in Europe and 2027 in the United States.

The more you know, the less you don't know.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent HALO News
More HALO News
InvestorsHub NewsWire

FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!